CHRETO ApS: Financial statements 2015
CVR: 33382170
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
CHRETO ApS (CVR 33382170) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 1,100,204 and a net result of DKK -5,646 compared with DKK 4,711 the year before. That is an increase of 23,253.9% compared with the year before. Equity in the 2015 report amounted to DKK 161,497. The solvency ratio was 9.3%.
- Gross Profit
- DKK 1,100,204
- Profit/Loss
- DKK -5,646
- Equity
- DKK 161,497
- Total Assets
- DKK 1,730,545
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 1.1 mio. | -6 t. | 161 t. | - |
| 2014 | - | 5 t. | 5 t. | 167 t. | - |
| 2013 | - | 13 t. | 13 t. | 162 t. | - |
Official annual report
How creditworthy is CHRETO ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout CHRETO ApS
CHRETO ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jan Kyhse-Andersen. The board consists of Johan Caspar Foghsgaard (chair), Anders Wikström, Frank Bech Nygaard and Kim Bjørnstrup. The company's owners include NOVOZYMES A/S, SKEIKAMPEN INVEST ApS and JAN KYHSE-ANDERSEN HOLDING ApS. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK -2,662,874 and a net result of DKK -3,119,901 compared with DKK -2,336,562 the year before. Equity in the 2025 report amounted to DKK 49,010,862.